Anovulation Clinical Trial
Official title:
Effect of Sildenafil Vaginal Gel Co-treatment With Clomiphene Citrate on Endometrial Thickness in Infertile Women With Prior Clomiphene Citrate Failure Due to Thin Endometrium: a Prospective Self-controlled Clinical Trial
This is a prospective self controlled clinical trial. Women with clomiphene Citrate failure, and thin endometrium were recruited (N = 42). In their 6th (Clomiphene citrate only) cycle, women continued on Clomiphene citrate 100 mg/ day for 5 days, and had sonographic measurement of their endometrial thickness , and Doppler evaluation of their uterine arteries on the day of HCG administration. In 7th cycle, women (N = 36) were given usual dose of Clomiphene citrate supplemented with sildenafil vagina gel (5 gm, containing 50 mg sildenafil) twice daily from cycle day 8 till the day of HCG injection. Endometrial thickness and uterine artery Doppler were measured on the day of HCG administration.
Study design:
This is a prospective self-controlled clinical trial.
Study subjects:
Investigators counseled and recruited 42 infertile women who had been diagnosed with
anovulatory infertility, with normal baseline FSH, LH, and free testosterone levels, patent
tubes on hysterosalpingography, and normal male semen analysis.
By the time they were enrolled in the study, all women had already completed 5 ovulatory
cycles of Clomiphene citrate induction (in a dose of 100 mg/ day in two divided doses
starting from day 3 of the cycle for 5 days) but without conception (clomiphene citrate
failure) with thin endometrium (<8mm) in at least 3 cycles. Ovulation was documented
sonographically, and with day-21 serum progesterone exceeding 5 ng/ ml in all cases.
Exclusion criteria:
Women with major medical problems, male factor infertility, endocrine abnormalities such as
hyperprolactinemia or abnormal thyroid functions, prior ovarian or adnexal surgery, or
organic pelvic pathology were not included in the study.
Intervention:
Sixth cycle (Clomiphene citrate only):
Enrolled cases were asked to continue with Clomiphene citrate induction ( at the same dose)
for the 6th cycle. A gel base, without medicament (vehicle only), was applied vaginally in a
dose of 5 gm twice per day, from cycle day 8 to the day of HCG administration ( when
follicular diameter reached 18 mm). Endometrial thickness and Uterine artery Doppler
assessment were done in the late proliferative phase ( Day of HCG injection).
Seventh cycle ( Sildenafil vaginal gel and Clomiphene cycle):
Those who didn't conceive on the sixth cycle (41 women) were asked to have an extra (7th)
cycle in which they were prescribed the usual dose of Clomiphene citrate in addition to
sildenafil vaginal gel. The sildenafil vaginal gel consists of sildenafil acetate as a
medicament loaded on an in situ gelling system based on two polymers: Pluronic p-127, and
Hydroxy Ethyl Cellulose. The dose was 5 g gel containing 50 mg sildenafil, applied vaginally
twice daily from cycle day 8 to Day of HCG injection. The gel was prepared in collaboration
with the department of pharmaceutics, faculty of Pharmacy, Assiut University. Sixty grams of
gel were prepared in tubes and every patient was given 10 applicators like that used for
administration of vaginal antimycotic creams to use them for applying the gel.
Evaluation of the study end points:
On day of HCG injection (main follicular diameter of 18 mm) in the 6th, and 7th cycles, women
came for follow up and had transvaginal sonographic assessment of their endometrial
thickness. Investigators have measured the maximal distance spanning endometrial- myometrial
interphase on each endometrial stripe in a sagittal plane in the fundus of the uterus. In
addition, Transvaginal Doppler examination was also done on the same visit to evaluate the
pulsatility indices of both uterine arteries. When the leading follicle reached 18 mm in
diameter, 5000 IU of HCG was prescribed for IM injection.
Although pregnancy rate was not a primary outcome measure in the study, investigators
detected pregnancy in 3 cases in the cohort of 36 cases of infertile women with clomiphene
failure in which sildenafil gel was added as an adjuvant. Pregnancy was diagnosed with a
B-HCG value above 100 mIU/ml, and confirmed later with ultrasound.
Statistics:
Data were analyzed using SPSS program ver. 17 using Student-t-test and Fisher's exact test
for comparing data in the 6th and 7th cycles, as appropriate.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01653743 -
Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women
|
Phase 3 | |
Completed |
NCT00327366 -
Effect of Bright Light on Sex Hormones and Ovulation in Humans
|
N/A | |
Not yet recruiting |
NCT02551367 -
Letrozole Versus Clomiphene Citrate for Ovulation Induction in Women With Poly Cystic Ovary Syndrome ( PCOS )
|
Phase 2 | |
Completed |
NCT01923194 -
Evaluation of Efficacy and Safety of Highly Purified Urofollitropin for Ovulation Induction in Chinese Females
|
Phase 3 | |
Completed |
NCT01008319 -
Traditional Clomiphene Citrate Administration vs. Stair-step Approach
|
Phase 3 | |
Completed |
NCT00239603 -
Efficacy Study of the OV-Watchâ„¢ Personal Fertility Monitor for Women Using Clomiphene Citrate.
|
Phase 4 | |
Recruiting |
NCT02309047 -
The Cycle Disturbances, OLigomenorrhea and Amenorrhea (COLA) Study & Biobank
|
||
Completed |
NCT03252223 -
Ovarian Response to Recombinant Follicle Stimulating Hormone in Women With PCOS
|
Phase 4 | |
Completed |
NCT00492882 -
Study of Mechanisms of Anovulation in Polycystic Ovary Syndrome
|
Phase 4 | |
Completed |
NCT02335879 -
Phase III Clinical Study of Domestic Recombinant Human Follitropin for Injection to Treat WHO Class II Anovulation
|
Phase 3 | |
Completed |
NCT00471523 -
Treatment of Anovulatory Infertility in PCOS Patients
|
Phase 4 | |
Completed |
NCT02703649 -
Administration of Single High Dose Letrozole for Ovulation Induction
|
Phase 4 | |
Completed |
NCT00213148 -
Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction
|
Phase 2 | |
Completed |
NCT03018314 -
Serum Kisspeptin Levels in Infertile Women
|
N/A | |
Recruiting |
NCT02186782 -
Concomitant CC and E2 Versus CC Alone in Ovulation Induction
|
Phase 4 | |
Not yet recruiting |
NCT00665171 -
Whole Genome Analysis for the Detection of Key Genes in the Polycystic Ovary Syndrome
|
N/A | |
Withdrawn |
NCT03155828 -
Using CPAP to Improve Menstruation in Women With Polycystic Ovarian Syndrome and Obstructive Sleep Apnea
|
||
Withdrawn |
NCT00453219 -
FHA: Characterization of Metabolic Status, Brain Circuitry, and Stress-Reactivity
|
N/A | |
Completed |
NCT00920634 -
Protocol for Drug Use Investigation of Follistim Injection (Study P06132)(COMPLETED)
|
||
Recruiting |
NCT06208995 -
Quality of Life in Normogonadotropic Anovulation
|